The Latest Breaking News from Novo Nordisk

The study represents the first long-term, large-scale, real-world trial of the blockbuster drug, researchers said.

After a run, stocks can offer a new buying opportunity with a pullback to the 50-day line. Novo Nordisk and 4 S&P 500 stocks have done that.

Novo Nordisk stock skidded Monday on reports an inspection turned up "objectionable conditions" at a diabetes and weight-loss drugs manufacturing plant.

Novo Nordisk, the maker of the blockbuster obesity injection, has singlehandedly saved the country from recession

The Nasdaq fell below its 50-day line with the market rally facing a big test. Meta is flirting with a buy point.

Ozempic has not shown increased risk of suicidal ideation in trials, but some users say it harmed their mental health.

In February 2021, The Conversation reported on a trial for a new weight-loss drug, called semaglutide, that was being hailed in the media as a “gamechanger”. Gamechanger is a word used far too often by journalists to describe things that are, frankly, mundane. This time, though, the word seems apt.

The Danish pharma giant overtook French luxury conglomerate LVMH as the most valuable European company, which held the title since 2021.

Danish drugmaker Novo Nordisk is now Europe's largest company in market capitalisation, ahead of French luxury giant LVMH. This follows the UK launch of Wegovy, a weight loss drug that cuts appetite and cravings. Tens of thousands of people have already signed up to waiting lists for the treatment. Also…